SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001273511-19-000079
Filing Date
2019-09-11
Accepted
2019-09-11 14:49:10
Documents
9
Period of Report
2019-09-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT DATED SEPTEMBER 3, 2019 phgform8k.htm 8-K 13708
2 AGREEMENT DATED SEPTEMBER 3, 2019 WITH EMERGING MARKETS CONSULTING, LLC exhibit101.htm EX-10.1 1317
3 exhibit101001.jpg GRAPHIC 303905
4 exhibit101002.jpg GRAPHIC 403205
5 exhibit101003.jpg GRAPHIC 409948
6 exhibit101004.jpg GRAPHIC 379706
7 exhibit101005.jpg GRAPHIC 320181
8 exhibit101006.jpg GRAPHIC 421096
9 exhibit101007.jpg GRAPHIC 202502
  Complete submission text file 0001273511-19-000079.txt   3376457
Mailing Address 2987 BLACKBEAR COURT COQUITLAM A1 V3E3A2
Business Address 2987 BLACKBEAR COURT COQUITLAM A1 V3E3A2 702-803-9404
Pharmagreen Biotech Inc. (Filer) CIK: 0001435181 (see all company filings)

IRS No.: 980491567 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-56090 | Film No.: 191088108
SIC: 4581 Airports, Flying Fields & Airport Terminal Services
Assistant Director 5